ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1115

B Cell-Intrinsic Interferon Gamma Signals Promote the Development of Systemic Lupus Erythematosus By Enhancing the Formation of Spontaneous Autoimmune Germinal Centers

Shaun Jackson, Nicole Scharping, Holly Jacobs, Tanvi Arkatkar, Socheath Khim and David Rawlings, Seattle Children's Research Institute, Seattle, WA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: autoantibodies, B cells, cytokines and interferons, Lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: B cell Biology and Targets in Rheumatolid Arthritis and other Autoimmune Disease Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Type 1 interferon (IFN) is strongly implicated in lupus pathogenesis, and SLE patients frequently express a “type 1 IFN gene signature”. The type 2 interferon, IFN gamma (IFN-γ), has also been implicated in lupus development via direct activation of autoreactive T cells. Although B cells are critical in lupus pathogenesis, whether these cytokines exert cell-intrinsic impacts on autoantibody-producing B cells has not been studied. We recently developed a chimeric murine lupus model in which Wiskott-Aldrich syndrome protein (WAS)-deficient B cells promote spontaneous humoral autoimmunity (Jackson, et al. J Immunol 2014). An important advantage of the WAS chimera model is that dysregulated immune responses are limited to the B cell compartment, allowing genetic manipulation in a B cell-intrinsic fashion. In the current study, we contrast the impact B cell-intrinsic type 1 interferon and IFN-γ signals on serum autoantibody titers, systemic inflammation and the development of lupus nephritis.

Methods: Using the WAS chimera model of spontaneous humoral autoimmunity, we deleted the type 1 IFN receptor (IFNAR) or IFN-γ receptor (IFNgR) on all hematopoietic cells (“global deletion”), or specifically on B cells (“B cell-intrinsic”). Chimeras were analyzed for autoantibodies, immune activation and immune-complex glomerulonephritis (IC GN) by ELISA, flow cytometry and immunohistochemistry.

Results: Surprisingly, although type 1 IFN enhanced B cell responses in vitro, B cell-intrinsic IFNAR deletion exerted minimal impacts on lupus pathogenesis. To address whether other cytokines promote B cell activation in this model, we quantified cytokine production ex vivo, and noted prominent CD4 T cell IFN-γ production in diseased WAS chimeras. Consistent with this, global IFNγR deletion prevented autoantibody (Ab) production and systemic inflammation in WAS chimeras. Strikingly, cell-intrinsic deletion of IFN-γR on either T cells or B cells recapitulated the phenotype of global IFNγR deficiency. Mechanistically, deletion of IFNγR on B cells prevented the formation of spontaneous germinal centers (GCs), required for class-switched Ab formation. Consistent with lack of serum autoantibodies, lupus nephritis was abrogated in B cell IFNγR-null chimeras.

In addition to Ab formation, B cells promote autoimmunity via antigen presentation and production of cytokines. Based on prominent B cell IFN-γ production in this model, we hypothesized that B cell-derived IFN-γ enhances spontaneous GC formation. In contrast, rendering B cells unable to produce IFN-γ did not alter the development of murine lupus suggesting that other cellular IFN-γ sources compensate for lack of B cell-derived IFN-γ.

Conclusion: We report the novel observation that IFN-γ, and not type 1 IFN, signals promote systemic lupus via direct actions on B cells. Mechanistically, IFN-γ promotes the formation of spontaneous autoimmune GCs via reciprocal activation of GC B cells and T follicular helper cells. To our knowledge, this study is the first to directly address the impact of B cell IFN-γ activation in murine lupus, of relevance to both the understanding of disease pathogenesis and to efforts to target IFN-γ therapeutically in SLE.


Disclosure: S. Jackson, None; N. Scharping, None; H. Jacobs, None; T. Arkatkar, None; S. Khim, None; D. Rawlings, None.

To cite this abstract in AMA style:

Jackson S, Scharping N, Jacobs H, Arkatkar T, Khim S, Rawlings D. B Cell-Intrinsic Interferon Gamma Signals Promote the Development of Systemic Lupus Erythematosus By Enhancing the Formation of Spontaneous Autoimmune Germinal Centers [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/b-cell-intrinsic-interferon-gamma-signals-promote-the-development-of-systemic-lupus-erythematosus-by-enhancing-the-formation-of-spontaneous-autoimmune-germinal-centers/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/b-cell-intrinsic-interferon-gamma-signals-promote-the-development-of-systemic-lupus-erythematosus-by-enhancing-the-formation-of-spontaneous-autoimmune-germinal-centers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology